New research examines the emerging benefits and unanswered questions surrounding this rapidly expanding class of…
Browsing: Semaglutide
Semaglutide is a medication primarily used to treat type 2 diabetes and obesity. It belongs to a class of drugs known as GLP-1 receptor agonists, which mimic the action of the naturally occurring hormone GLP-1 to increase insulin secretion, reduce appetite, and slow down digestion. This helps in better blood sugar control and weight loss. Semaglutide is available in injectable forms and as an oral tablet, and it has been shown in clinical trials to be highly effective in improving glycemic control and aiding significant weight loss, making it a valuable option for managing these conditions.
Why do drugs like Ozempic produce far greater and more lasting weight loss than older…
New research suggests GLP-1 medications may be associated with a lower likelihood of developing breast…
Widely used GLP-1 drugs, including Ozempic and Mounjaro, may carry an unexpected downside: a small…
Researchers say treatment decisions should be individualized by weighing expected benefits, potential harms, treatment burden,…
Experts say the future of obesity treatment will extend far beyond GLP-1 drugs by combining…
Semaglutide was linked to greater weight loss and a 15% lower fracture risk in people…
Semaglutide delivered dramatic weight loss and health benefits in adults over 65, offering new hope…
Ozempic and similar weight-loss drugs were linked to a striking 30% reduction in breast cancer…
Researchers identified a strong association between GLP-1 medications and reduced rates of multiple substance use…
A widely prescribed class of weight-loss and diabetes medications may be doing more than improving…
Scientists may have found the brain-cell switch that determines how long Ozempic’s weight-loss effects last.…
Stopping Ozempic doesn’t always lead to major weight regain, according to a large new study.…
A new study shows oral GLP-1 drugs suppress hedonic eating through a deep-brain reward circuit…
New research indicates that maintaining meaningful weight loss after starting GLP-1-based therapies could play an…
New research suggests that the promise of GLP-1 weight loss drugs is accompanied by an…
A large-scale analysis suggests that GLP-1 receptor agonists may do more than manage weight or…
A new study suggests that the effectiveness of widely used GLP-1 weight-loss drugs may depend…